Clinical Trials
34 trialsNCT06369480 2024-04-17
Prognostic Factors for Survival in Patients With Cholangiocarcinoma
Rigshospitalet, Denmark
Unknown
NCT06208436 2024-01-17
The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Unknown
NCT04308837 2023-11-14
A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation
Icahn School of Medicine at Mount Sinai
Phase 2 Unknown
NCT04755907 2022-07-19
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
Peking Union Medical College Hospital
Unknown
NCT04664504 2021-06-08
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
ChineseAMS
Phase 2 Unknown
NCT04747951 2021-02-15
Total Neoadjuvant Therapy in Rectal Cancer Treatment
State Scientific Centre of Coloproctology, Russian Federation
Phase 4 Unknown
NCT04737551 2021-02-04
Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study
Shanghai Zhongshan Hospital
Unknown
NCT04198051 2019-12-13
The Clinical Study of Adjuvant Chemotherapy on Intestinal and Urethral Flora in Patients With Gastric and Colon Cancer
The First Affiliated Hospital of Dalian Medical University
Phase NA Unknown
NCT01047969 2019-06-13
Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT02404753 2018-09-28
REALIZATION
Peking University
Phase 2 Unknown
NCT03177382 2018-05-08
TNTCRT
West China Hospital
Phase 3 Unknown
NCT03071198 2017-03-07
Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy
Harbin Medical University
Phase NA Unknown
NCT00450203 2016-12-01
ST03
Medical Research Council
Phase 2/3 Unknown
NCT02960061 2016-11-09
HIPEC
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Unknown
NCT02738697 2016-11-02
Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection
Sun Yat-sen University
Phase 3 Unknown
NCT02891083 2016-09-07
Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer
Shanghai Chest Hospital
Phase 3 Unknown
NCT02648841 2016-01-07
A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.
ChineseAMS
Phase 3 Unknown
NCT02280278 2014-11-05
Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy
Sun Yat-sen University
Phase 3 Unknown
NCT00077389 2014-06-24
Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00027768 2013-09-20
Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00046995 2013-09-20
Combination Chemotherapy in Treating Patients With Colon Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00088816 2013-09-17
S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00134095 2013-09-17
S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00276705 2013-09-17
Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01097265 2013-08-12
Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2/3 Unknown
NCT00002455 2013-08-07
Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00482222 2013-01-23
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
University of Southampton
Phase 3 Unknown
NCT00438737 2011-09-02
Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00471484 2011-06-22
Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00006479 2011-04-18
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00383695 2010-01-13
EXPERT-C
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT00513266 2009-08-07
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00072553 2009-02-09
Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00091312 2009-02-09
Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
National Cancer Institute (NCI)
Phase 3 Unknown